Western blot assays showed that the knockdown of Nanos3 significantly decreased the protein expression of CD133, Oct4, Dazl, and Ki67 in these glioblastoma cell lines but did not alter the expression of β-catenin (Additional file 1: Figure S3a). The gene discussed is PROM1; the disease is glioblastoma.